Trial · NCT01619085
Adverse events3,184
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,184
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Total (1199.32/.34) | 63 | 734 | |
| other | Abdominal pain | Gastrointestinal disorders | Placebo (1199.32/.34) | 32 | 304 | |
| other | Abdominal pain | Gastrointestinal disorders | Nintedanib 150 Bid (1199.32/.34) | 31 | 430 | |
| other | Abdominal pain | Gastrointestinal disorders | Placebo (1199.187) | 0 | 7 | |
| other | Abdominal pain | Gastrointestinal disorders | Nintedanib 100 Bid (1199.35) | 0 | 2 | |
| other | Abdominal pain | Gastrointestinal disorders | Nintedanib 150 Bid (1199.35/.187) | 0 | 8 | |
| other | Abdominal pain | Gastrointestinal disorders | Total (1199.35/.187) | 0 | 17 | |
| other | Abdominal pain | Gastrointestinal disorders | Total (1199.32/.34/.35/.187) | 63 | 751 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Total (1199.32/.34) | 48 | 734 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo (1199.32/.34) | 21 | 304 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Nintedanib 150 Bid (1199.32/.34) | 27 | 430 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo (1199.187) | 0 | 7 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Nintedanib 100 Bid (1199.35) | 0 | 2 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Nintedanib 150 Bid (1199.35/.187) | 0 | 8 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Total (1199.35/.187) | 0 | 17 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Total (1199.32/.34/.35/.187) | 48 | 751 | |
| other | Constipation | Gastrointestinal disorders | Total (1199.32/.34) | 57 | 734 | |
| other | Constipation | Gastrointestinal disorders | Placebo (1199.32/.34) | 26 | 304 | |
| other | Constipation | Gastrointestinal disorders | Nintedanib 150 Bid (1199.32/.34) | 31 | 430 | |
| other | Constipation | Gastrointestinal disorders | Placebo (1199.187) | 0 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01619085/events